Certificate in Psychedelic-Assisted Therapies (CPAT)™ · Mind Medicine Australia
Mind Medicine Australia logo
Donate

Certificate in Psychedelic-Assisted Therapies (CPAT)™

Apply now!
Certificate in Psychedelic-Assisted Therapies (CPAT)™

Applications for February 2025 intake close on November 30.
Don’t miss out! Places are filling fast.

We also strongly recommend applying for July 2025 intake asap.

Apply Today!

CPAT™ is accepting applications now from clinicians all over Australia, New Zealand and the Asia Pacific for our July 2024 intake. Don’t miss out on learning with the world’s best in psychedelics and healing the suffering.

Mind Medicine Australia (MMA) is a charity that seeks to alleviate the suffering caused by mental illness in Australia through expanding the treatment options available to medical practitioners and their patients. We are focused on the development of safe and effective psychedelic-assisted therapies to cure a range of mental illnesses.

To this end, MMA has developed the Certificate in Psychedelic-Assisted Therapies (CPAT)™ in collaboration with leading PAT practitioners in the USA and UK.

The Certificate in Psychedelic-Assisted Therapies (CPAT)™ by Mind Medicine Australia (MMA) is a part online and part face-to-face professional training that provides registered healthcare professionals with the knowledge and skills to safely and effectively administer psychedelic-assisted therapies (PAT) in clinical settings. This program is both for prescribing psychiatrists, as well as other mental health professionals who will be delivering the treatment as part of a multidisciplinary team.

The training is delivered by a world-class faculty made up of global leaders in the field. It teaches best practice for the delivery of PAT, with a focus on psilocybin, MDMA and ketamine-assisted therapy. These are the three psychedelic medicines with regulatory approval in Australia.

In February 2023 the TGA approved Mind Medicine Australia’s application to reschedule the substances psilocybin and MDMA from Schedule 9 (prohibited substances) to Schedule 8 (controlled medicines) of the Poisons Standard. With this rescheduling, psychiatrists who have the requisite approvals are now able to utilise psilocybin for treatment-resistant depression and MDMA for PTSD. These changes came into effect July 1st, 2023.

Testimonials

“This course is the gold standard for training in psychedelic therapies. The scientific rigor and depth will challenge even seasoned medical practitioners. The breadth and openness of the application of complementary holistic practices will challenge and broaden the worldview of therapeutic potential. I am a better psychiatrist and better person for having participated. Let’s build to great heights so we can witness deeper horizons together.” 

Dr Julian Dodemaide, Psychiatrist, QLD 

“MMA is changing the landscape of mental health care in Australia and the world, not only in introducing MDMA, psilocybin & ketamine treatment but also in teaching an approach that is holistic, mindful, patient centered and revolutionary. I benefited from the training from world-leading experts in the field and most of all, I leave residential as a changed practitioner, with the ability to be much more fully present to patients’ experiences & journey. Very grateful for the MMA leaders who contributed to our learning with generosity, grace and a lightness of spirit combined with a depth of knowledge. Much Gratitude.” 

Claire Gomez, Registered Nurse, NSW

“There are so many words to describe this experience but the one that comes to me is profound. The space the facilitators created was one of respect, trust and safety, and this allowed participants to drop in, be vulnerable and engage in and with learning and personal growth. There are so many elements of learning that I will take away from this experience and integrate into my personal and professional life. I cannot thank MMA enough. Much gratitude and love.” 

Narissa Miller, Psychologist, QLD 

Course accreditation

Mind Medicine Australia’s Certificate in Psychedelic-Assisted Therapies™ is accredited by the Australian Medical CPD Standard.

Psychiatrists & other Medical Doctors

CPAT™ is accredited for 113 hours of Educational Activity and 14 hours of Reviewing Performance, under the new CPD Program for Medical Practitioners. It has been peer-reviewed by an independent panel of psychiatrists.

Psychologists & other Healthcare Professionals

CPAT™ is accredited for 127 hours of CPD. It has been peer-reviewed by an independent panel of psychologists.

All our training courses and events may also be used to claim ongoing Continuing Professional Development (CPD) points in Australia through your professional colleges or associations. Please check with your professional membership body for the appropriate category and number of points.

Financial assistance

Financial assistance is available for our Certificate in Psychedelic-Assisted Therapies (CPAT)™!

The funding is available for outstanding practitioners in financial need and those from rural, regional areas and/or those from indigenous or other diverse groups to support part of the tuition fees for the course. Some financial assistance is available on a competitive basis.

The Fundamentals of Psychedelic-Assisted therapies for Mental Health

Mind Medicine Australia is delighted to announce the launch of a new online course, The Fundamentals of Psychedelic-Assisted therapies for Mental Health. This course will help people understand the foundations of psychedelic-assisted therapies and the application of their use in the treatment of chronic mental illness. This course is open to anyone with an interest in the topic.

You can see what the program will cover here:

Psychedelic Fundamentals Overview >>

Subscribe to our newsletter

Stay in touch with Mind Medicine Australia:

×